New York To Prioritize Non-White People In Distributing COVID-19 Treatments

Non-White individuals will be given priority in the distribution of COVID-19 treatments, which are in low supply in the state of New York.

The New York State Department of Health issued a letter outlining their strategy for distributing treatments such as monoclonal antibody therapy and antiviral pills to the public.

The letter mentions eligibility for the low-supply antiviral pills and says people who receive the medication need to have “a medical condition or other factors that increase their risk for severe illness.”

One noted “risk factor” is being a part of a ethnicity or race that is not white due to “longstanding systemic health and social inequities.”

The memo says, “Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19.”

New York’s plan faced scrutiny on social media for their discrimination based on skin color and ethnicity.

The state of New York is seeing a record number of COVID-19 cases, which prompted the state to distribute the medical treatments.

New York City has seen a rise in anti-vaccine mandate protests in recent months. This past week, five individuals were arrested by NYPD after refusing to leave a fast food restaurant after they were denied service due to lack of vaccination.

Similar anti-vaccine passport demonstrations have arisen across Europe, with demonstrators accusing governments of preventing the unvaccinated from leading their lives as normally as they would have otherwise.

The New York Department of Health did not reply to a request for comment from Fox News.

Stay tuned to The Scoop for any updates.